Free. Unsubscribe any time.
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. filed 15 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 26 transactions and 1,051,819 shares. 15 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-02-04, came on the same day as the one before it (2026-02-04) and reports 3 transactions against 2 in the filing before it.
- The sales it reports total 69,772 shares, 20,248 more than the 49,524 in the filing before it.
- Its 15 plan statements rank 327th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 15 filings on file run from 2025-02-04 to 2026-02-04, and state 8 plan adoption dates, from 2023-11-17 to 2025-09-09.
Trades in Akebia Therapeutics, Inc. 26
- Burke Steven Keith — 2025-02-03 · S · 23,270 shares
- Burke Steven Keith — 2025-02-03 · S · 27,236 shares
- Butler John P. — 2025-02-03 · S · 46,268 shares
- Butler John P. — 2025-02-03 · S · 97,982 shares
- Grund Nicholas — 2025-02-03 · S · 55,621 shares
- Malabre Richard C — 2025-02-03 · S · 30,202 shares
- Burke Steven Keith — 2025-03-03 · S · 7,144 shares
- Butler John P. — 2025-03-03 · S · 46,409 shares
- Malabre Richard C — 2025-06-04 · S · 13,334 shares
- Malabre Richard C — 2025-06-09 · S · 15,000 shares
- Ostrowski Erik — 2025-06-30 · S · 41,314 shares
- Burke Steven Keith — 2026-02-02 · S · 21,582 shares
Adoption dates in Akebia Therapeutics, Inc. 8
- 2023-11-17 — stated in 3 filings
- 2023-12-01 — stated in 2 filings
- 2023-12-23 — stated in 1 filing
- 2024-05-13 — stated in 1 filing
- 2024-06-21 — stated in 1 filing
- 2024-12-12 — stated in 2 filings
- 2025-09-08 — stated in 4 filings
- 2025-09-09 — stated in 1 filing
Results prints in Akebia Therapeutics, Inc. 8
- 2025-03-13
- 2025-05-08
- 2025-08-07
- 2025-11-10
- 2026-01-12
- 2026-02-26
- 2026-05-07
- 2026-08-05
Trades before a print in Akebia Therapeutics, Inc. 0
- 10 days before the 2025-03-13 print — 2025-03-03 · S · Burke Steven Keith · 7,144 shares
- 10 days before the 2025-03-13 print — 2025-03-03 · S · Butler John P. · 46,409 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Burke Steven Keith · 21,582 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Burke Steven Keith · 25,375 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Burke Steven Keith · 20,701 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Butler John P. · 46,660 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Butler John P. · 96,065 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Butler John P. · 114,891 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Butler John P. · 83,689 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Grund Nicholas · 53,585 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Grund Nicholas · 31,244 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · Malabre Richard C · 36,142 shares
Interval to Akebia Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 2within 10 days
- 10shortest, days
- 0no later print
- Burke Steven Keith 2025-03-03 · S · 10 days before the 2025-03-13 print · SVP, Chief Medical Officer
- Butler John P. 2025-03-03 · S · 10 days before the 2025-03-13 print · CEO and President
Adoption dates Akebia Therapeutics, Inc. states
- 2023-11-17 in 3 filings
- 2023-12-01 in 2 filings
- 2023-12-23 in 1 filing
- 2024-05-13 in 1 filing
- 2024-06-21 in 1 filing
- 2024-12-12 in 2 filings
- 2025-09-08 in 4 filings
- 2025-09-09 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on May 13, 2024”
Reported results dates on file
- 2025-03-13
- 2025-05-08
- 2025-08-07
- 2025-11-10
- 2026-01-12
- 2026-02-26
- 2026-05-07
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.